• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Biomed Res Int . Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients

tetano

Editor, Senior Moderator
Biomed Res Int


. 2021 Dec 8;2021:7073348.
doi: 10.1155/2021/7073348. eCollection 2021.
Frequency of Cardiovascular Complications and Its Association with Prognosis of COVID-19 Patients


Hossein Mazaherpour[SUP] 1 [/SUP], Masoumeh Soofian[SUP] 1 [/SUP], Elham Farahani[SUP] 1 [/SUP], Fatemeh Masfari Farahani[SUP] 1 [/SUP], Ehsanollah Ghaznavi Rad[SUP] 1 [/SUP], Sakine Mazaherpour[SUP] 2 [/SUP], Yousef Ramazani[SUP] 3 [/SUP], Fatemeh Ashrafian[SUP] 4 [/SUP], Amitis Ramezani[SUP] 4 [/SUP]



Affiliations

Abstract

Coronavirus disease 2019 (COVID-19) may lead to acute respiratory disease; cardiovascular, gastrointestinal, and coagulation complications; and even death. One of the major complications is cardiovascular disorders, including arrhythmias, myocarditis, pericarditis, and acute coronary artery disease. The aim of this study was to evaluate the frequency of cardiovascular complications and to determine its association with the prognosis of COVID-19 patients. In a prospective analytic study, 137 hospitalized COVID-19 patients were enrolled. During hospitalization, an electrocardiogram (ECG) was performed every other day, and laboratory tests such as cardiac troponin I (cTnI) and creatine kinase-MB (CK-MB) were done 0, 6, and 12 hours after admission. These tests were repeated for patients with chest pain or ECG changes. Patients were categorized into three groups (improved, complicated, and expired patients) and assessed for the rate and type of arrhythmias, cardiac complications, lab tests, and outcomes of treatments. There was no significant relationship among the three groups related to primary arrhythmia and arrhythmias during treatment. The most common arrhythmia during hospitalization and after treatment was ST-T fragment changes. There was a significant age difference between the three groups (P = 0.001). There was a significant difference among the three groups for some underlying diseases, including diabetes mellitus (P = 0.003) and hyperlipidemia (P = 0.004). In our study, different types of arrhythmias had no association with patients' outcomes but age over 60 years, diabetes mellitus, and hyperlipidemia played an important role in the prognosis of COVID-19 cases.
 
Back
Top Bottom